Tag: OTCQB:BSGM

September 19, 2018

BioSig Technologies to Commence Trading on the Nasdaq

BioSig Technologies (OTCQB:BSGM, OTCQB:BSGMD), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet...
August 14, 2018

BioSig Receives FDA 510(k) Clearance, Share Price Decreases

BioSig Technologies has had a successful first half of August, with its FDA clearance being just one of several steps...
August 14, 2018

BioSig Technologies Announces FDA 510(k) Clearance for PURE EP System

BioSig Technologies (OTCQB:BSGM), announced that the Company has received 510(k) clearance for its first product, PURE EP System, from the...
February 10, 2017

BioSig Technologies Donates to American Heart Association in Sponsorship of American Heart Month

BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP(TM) System, a proprietary platform designed to address...
January 30, 2017

BioSig Technologies Announces EU Institutional Investor Roadshow

BioSig Technologies (OTCQB:BSGM), a medical device company developing the PURE EP(TM) System, a proprietary platform designed to address an unmet...
January 20, 2017

BioSig Technologies Issues Shareholder Letter

BioSig Technologies (OTCQB:BSGM), a medical device company developing the PURE EP(TM) System, a proprietary platform designed to address an unmet...
January 11, 2017

BioSig Technologies ’ PURE EP System Featured in The Journal of the American College of Cardiology: Clinical Electrophysiology

BioSig Technologies (OTCQB:BSGM), a medical device company developing a proprietary technology platform designed to improve the $4 billion electrophysiology (EP)...